Boditech Med ㅡ "Leading in-vitro diagnostic market with flexible and quick decision making"

Hello, I am Heejae Park in charge of Global Sales Division 1 as a Sales Director. After being in the pharmaceutical industry for about 30 years, I’ve accepted a new challenge and joined the in-vitro diagnostics industry since last year. Although it’s a new and unfamiliar territory, it gives me immense joy to take up a very prestigious role that contributes directly to our nation’s economy in such unprecedented times as this.  

My duty includes leading sales of 25 countries in Asia, including Korea, Japan, and China. Besides focusing on COVID-19 related sales, I’m working on introducing new parameters and platforms to prepare for POST COVID-19 market and developing new distributors to expand our sales-reach to new markets.

It has barely been a year since I joined Boditech Med, but via constant communication with numerous distributors from 25 countries, I’ve come to get trend and meaningful insight of in-vitro diagnostic. Especially, we generated explosive sales revenue with COVID-19 related parameters in the short term from several countries. I’ve also worked on developing new distributors that have a lot of sales potential. We were also successful in overcoming the inconvenience caused by COVID-19 pandemic through virtual conferences and online meetings. 

It seems that the advantages that comes with following detailed-oriented operations, flexible management and fast-decision have led the company’s growth. Moreover, it is an organization that values the bond between employees that can be felt at the company cafeteria that serves generously with a family-like mindset.     

Besides the current platforms, the core foundation of Boditech Med’s growth is its future-oriented technology and a wide-distribution network in 130 countries worldwide. I am confident that it is a company that can provide a healthy and enjoyable workplace until retirement age, and beyond.